Breaking News Instant updates and real-time market news.

CHK

Chesapeake

$1.28

-0.055 (-4.12%)

, ADT

ADT Inc.

$6.21

-0.11 (-1.74%)

08:45
10/09/19
10/09
08:45
10/09/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Chesapeake (CHK) 5.60% +1.32, ADT (ADT) 13.27% +1.10, Inseego (INSG) 23.30% +0.49, McDermott (MDR) 12.28% +0.44, CrowdStrike Holdings (CRWD) 17.52% +0.34, Beyond Meat (BYND) 188.68% +0.23, Neptune Technologies (NEPT) 15.49% +0.17, Tata Motors (TTM) 0.45% +0.16, Enterprise Products (EPD) 0.40% +0.15, and Direxion Daily 20 plus Year Treasury Bull 3X Shares (TMF) 4.89% +0.13.

CHK

Chesapeake

$1.28

-0.055 (-4.12%)

ADT

ADT Inc.

$6.21

-0.11 (-1.74%)

INSG

Inseego

$4.82

-0.045 (-0.93%)

MDR

McDermott

$1.80

(0.00%)

CRWD

Crowdstrike

$65.29

-3.34 (-4.87%)

BYND

Beyond Meat

$143.13

-1.92 (-1.32%)

NEPT

Neptune Wellness

$3.74

-0.03 (-0.80%)

TTM

Tata Motors

$8.11

-0.18 (-2.17%)

EPD

Enterprise Products

$27.60

-0.32 (-1.15%)

  • 12

    Nov

  • 12

    Nov

  • 12

    Dec

CHK Chesapeake
$1.28

-0.055 (-4.12%)

08/08/19
RAJA
08/08/19
DOWNGRADE
RAJA
Market Perform
Chesapeake's outspend gap wider than expected, says Raymond James
Raymond James analyst John Freeman downgraded Chesapeake Energy to Market Perform from Outperform saying the company's outspend gap is wider than he expected. In a research note to investors, Freeman says that while Chesapeake has made a lot of progress pivoting to oilier assets, the preliminary 2020 outlook discussed by management suggests that the cash flow outspend gap remains much wider than he had previously anticipated. The analyst believes more pressure is placed on executing non-core asset sales to shore up the balance sheet, given capital requirements over the next several years.
09/30/19
SBSH
09/30/19
NO CHANGE
Target $22
SBSH
Buy
New Fortress Energy price target raised to $22 from $18 at Citi
Citi analyst Ryan Levine raised his price target for New Fortress Energy (NFE) to $22 from $18 to reflect benefits from low gas prices as well as the company's potential to renegotiate with Chesapeake (CHK). The analyst keeps a Buy rating on New Fortress Energy.
08/08/19
RAJA
08/08/19
DOWNGRADE
Target $3
RAJA
Market Perform
Chesapeake downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst John Freeman downgraded Chesapeake Energy to Market Perform from Outperform saying the company's outspend gap is wider than he expected.
06/28/19
06/28/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) upgraded to Buy from Neutral at Goldman Sachs with analyst Jason English saying there is room for further relative outperformance of the shares despite their 41% rise over the past 52 weeks. 2. AutoZone (AZO) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Nagel saying he is incrementally optimistic in its underlying potential after having spent considerable time with senior leadership at the firm's recent conference. 3. Chesapeake (CHK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Devin McDermott saying he now see a clearer path toward lower leverage and that his recent time with management pointed toward solid execution on operational improvements. 4. Smart Global (SGH) upgraded to Buy from Hold at Needham analyst Rajvindra Gill saying the shares are down 31% since the start of 2019 as its Brazil segment continues to be pressured by falling memory pricing. 5. KB Home (KBH) upgraded to Market Perform from Underperform at Raymond James with analyst Buck Horne saying the company's "healthy" orders in Q2 mitigate the downside risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ADT ADT Inc.
$6.21

-0.11 (-1.74%)

05/13/19
05/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) and Titan Machinery (TITN) downgraded to Neutral from Outperform at Baird. 2. Boot Barn (BOOT) downgraded to Hold from Buy at Pivotal Research with analyst Mitch Kummetz saying he sees a less favorable risk/reward at current share levels heading into the company's results on May 16. He does not see enough room for upside to his estimates, mainly because he believes oil and gas employment is becoming a "diminishing tailwind." 3. Shopify (SHOP) downgraded to Neutral from Buy at Guggenheim with analyst Ken Wong saying he sees upside potential as limited given the stock's current valuation, which he notes has now passed previous peak levels. 4. ADT Inc. (ADT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Toni Kaplan saying she has less confidence in the company's growth outlook following a recent AlphaWise survey conducted by the firm. 5. 51job (JOBS) downgraded to Neutral from Buy at Citi with analyst Alicia Yap saying she believes weakening operating metrics, such as a faster rate of decline for active employer count and slower rate of growth of ARPU, may be signals of challenges for online recruitment revenue growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/13/19
MSCO
05/13/19
DOWNGRADE
Target $7
MSCO
Equal Weight
ADT Inc. downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Toni Kaplan downgraded ADT Inc. (ADT) to Equal Weight from Overweight as she has less confidence in the company's growth outlook following a recent AlphaWise survey conducted by the firm. The survey showed homeowners seem as inclined to buy DIY systems as ADT systems, that more ADT customers switched to DIY providers than she would have expected and that measure of brand preference for Amazon's (AMZN) Ring and Google's (GOOG) Nest were higher than for ADT, Kaplan explains. Given that the survey leads her to fear ADT may find it difficult to defend its market share, Kaplan lowered her price target on the stock to $7 from $9.
03/15/19
IMPC
03/15/19
NO CHANGE
Target $12
IMPC
Outperform
ADT Inc. price target lowered to $12 from $15 at Imperial Capital
Imperial Capital analyst Jeff Kessler lowered his price target for ADT Inc. to $12 from $15 saying "heavy" investment translated to reduced free cash flow guidance for 2019. The analyst, however, sees continued revenue growth for ADT and maintains an Outperform rating on the shares.
03/12/19
SBSH
03/12/19
DOWNGRADE
Target $8.25
SBSH
Neutral
ADT Inc. downgraded to Neutral from Buy at Citi
Cit downgraded ADT Inc. to Neutral from Buy and lowered its price target for the shares to $8.25 from $13. The firm sees a less certain free cash flow trajectory following ADT's Q4 results.
INSG Inseego
$4.82

-0.045 (-0.93%)

05/24/19
COWN
05/24/19
INITIATION
COWN
Outperform
Inseego initiated with an Outperform at Cowen
05/24/19
COWN
05/24/19
INITIATION
Target $8
COWN
Outperform
Inseego initiated with an Outperform, $8 target at Cowen
Cowen analyst Lance Vitanza started Inseego with an Outperform rating and $8 price target. The company has a strong position within the "burgeoning" 5G market, Vitanza tells investors in a research note. With an estimated 20% annual revenue growth over the next few years, the stock deserves a premium valuation, says the analyst. He sees a "multitude of multi-billion-dollar market segments" to which Inseego technology can serve.
05/24/19
05/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Perform at Oppenheimer. 2. CannTrust (CTST) initiated with a Buy at BofA/Merrill. 3. Inseego (INSG) initiated with an Outperform at Cowen. 4. Falcon Minerals (FLMN) initiated with an Outperform at Baird. 5. Aphria (APHA) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/19
ROTH
09/20/19
NO CHANGE
Target $7
ROTH
Buy
Inseego actively engaged with over a dozen 5G trials, says Roth Capital
Roth Capital analyst Scott Searle said 5G continues to be the integral driver for Inseego, stating that he "conservatively" believes the company is actively engaged with over one-dozen 5G trial and certification processes, the majority of which he expects to result in deployments. Searle maintains a Buy rating and $7 price target on Inseego shares.
MDR McDermott
$1.80

(0.00%)

09/19/19
SBSH
09/19/19
NO CHANGE
Target $7
SBSH
Neutral
Citi sees working capital unwind as 'legitimate risk' for McDermott
Shares of McDermott dropped 63% yesterday following news that the company hired turnaround firm AlixPartners for "strategic and operational advice." Low liquidity, high leverage, and lingering headwinds associated with legacy CB&I-related projects pose elevated risk for the company, Citi analyst Andrew Kaplowitz tells investors in a research note. The analyst admits that he does not know what's causing McDermott to turn to AlixPartners. He sees a "wide range of possibilities with little visibility to near-term outcomes," which leads to his continued Neutral rating on the shares. McDermott has a "considerable amount of good assets" that are saleable and customers have an incentive to see the company succeed, says Kaplowitz. However, a working capital unwind is now a "legitimate risk" and it may be harder for McDermott to win work at this point, adds the analyst.
09/20/19
FBCO
09/20/19
NO CHANGE
Target $7
FBCO
Neutral
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
Credit Suisse analyst Jamie Cook says McDermott's announcement that it will explore selling its Lummus technology business was considered "a last resort," but was "unfortunately needed" to improve the balance sheet. Cook, who maintains a Neutral rating and $7.00 price target, says she believes McDermott would prefer to retain some ownership in order to retain rights to be the first bidder on the EPC business if possible. She feels a transaction could occur "quickly," given the asset was already on the market recently and says she believes the stock should rally on this news given the dramatic sell off this week and that management is not considering chapter 11.
09/11/19
SBSH
09/11/19
NO CHANGE
Target $7
SBSH
Neutral
McDermott price target lowered to $7 from $11 at Citi
Citi analyst Andrew Kaplowitz lowered his price target for McDermott to $7 from $11 while keeping a Neutral rating on the shares. While the analyst sees "some light at the end of the tunnel" for the company on its two "troublesome" liquefied natural gas projects and believes the negative estimate revisions for CBI Legacy work may be behind the company, he says he can't rule out "further project-related noise." Further, McDermott's balance sheet is still relatively levered and some uncertainty regarding the timing of asset sales remains, Kaplowitz tells investors in a research note.
10/31/18
KEYB
10/31/18
DOWNGRADE
KEYB
Sector Weight
McDermott downgraded to Sector Weight from Overweight at KeyBanc
CRWD Crowdstrike
$65.29

-3.34 (-4.87%)

10/03/19
10/03/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Raytheon (RTN) upgraded to Outperform from Neutral at Credit Suisse WITH analyst Robert Spingarn saying he believes United Technologies' (UTX) aerospace businesses are undervalued and that the market has yet to appropriately discount Raytheon's ~43.1% ownership of the proposed combined entity. 2. Wipro (WIT) upgraded to Neutral from Sell at Goldman Sachs with analyst Sumeet Jain citing valuation. 3. Dova Pharmaceuticals (DOVA) upgraded to Neutral from Underweight at JPMorgan with analyst Joel Fishbein saying the company's "strong" execution continues to drive "impressive growth at scale" as customer deal sizes grow amid larger initial deployments and customers adopting multiple products. 4. Crowdstrike (CRWD) upgraded to Buy from Hold at SunTrust with analyst Joel Fishbein saying the company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption." 5. Newmont Goldcorp (NEM) upgraded to Buy from Hold at Deutsche Bank with analyst Chris Terry saying shares of Newmont have significantly underperformed compared to its closest peer Barrick Gold (GOLD) and also versus the gold price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/02/19
RHCO
10/02/19
UPGRADE
Target $80
RHCO
Buy
Crowdstrike upgraded to Buy from Hold at SunTrust
SunTrust analyst Joel Fishbein upgraded Crowdstrike to Buy from Hold with an unchanged price target of $80.
10/02/19
RHCO
10/02/19
UPGRADE
Target $80
RHCO
Buy
SunTrust upgrades 'category-defining' Crowdstrike to Buy from Hold
SunTrust analyst Joel Fishbein upgraded Crowdstrike to Buy from Hold with an $80 price target after taking over coverage from Terry Tillman. The company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption," Fishbein tells investors in a research note. While the shares are not inexpensive, there are "several catalysts," including success in trial to pay, deeper penetration in both federal and international markets, and leverage from Crowdstrike's Dell relationship, contends the analyst.
10/08/19
JEFF
10/08/19
INITIATION
Target $67
JEFF
Hold
Crowdstrike assumed with a Hold rating at Jefferies
Jefferies analyst Brent Thill assumed coverage of Crowdstrike with a Hold rating and price target of $67, down from $80. The analyst last night assumed coverage of the Software industry and adjusted some of his ratings to be more defensive in light of valuation and macroeconomic concerns. However, he remains positive on the industry and believes that the fundamentals of businesses in the space are "very strong."
BYND Beyond Meat
$143.13

-1.92 (-1.32%)

09/26/19
SPHN
09/26/19
NO CHANGE
Target $230
SPHN
Overweight
Stephens doesn't see 'full blown' alternative beef rollout at McDonald's in U.S.
After McDonald's (MCD) announced plans for a 12-week test in Canada of a new plant-based burger using a Beyond Meat (BYND) patty, Stephens analyst Will Slabaugh said he is happy to see the burger giant consider an entry into the plant-based market. However, he is not expecting a near-term "full blown" alternative beef rollout in the U.S., primarily due to supply chain reasons. He views an alternative chicken product as more likely for a nation-wide launch in 2020/2021 in the U.S. in conjunction with exclusive poultry provider Tyson (TSN). He also thinks a chicken product would likely be "more novel" and a larger sales driver, said Slabaugh, who keeps an Overweight rating and $230 price target on McDonald's shares.
09/26/19
WBLR
09/26/19
NO CHANGE
WBLR
Market Perform
William Blair encouraged, but not surprised, by McDonald's testing Beyond Meat
William Blair analyst Jon Andersen is not surprised by the announcement that McDonald's (MCD) will conduct a 12-week test in Canada of a plant-based burger made with patties from Beyond Meat (BYND). However, the analyst is encouraged by Beyond Meat's involvement, pointing out that many major burger chains have added plant-based options amid rising consumer interest and demand, and better product technology. This includes Carl's Jr. Beyond Famous Star burger, Burger King's new Impossible Whopper, and White Castle's Impossible slider, Andersen points out in a research note. He keeps a Market Perform rating on Beyond Meat, whose stock is up 13%, or $18.28, to $156.60 in early trading.
09/23/19
EXAN
09/23/19
INITIATION
EXAN
Underperform
Beyond Meat initiated with an Underperform at Exane BNP Paribas
09/26/19
JEFF
09/26/19
NO CHANGE
Target $190
JEFF
Hold
Beyond Meat to 'squeeze sharply higher' after McDonald's news, says Jefferies
Jefferies analyst Kevin Grundy said McDonald's (MCD) interest in Beyond Meat (BYND) makes sense for both sides and the announcement of a trial by the burger giant "is what bulls have been waiting for" given McDonald's 38,000 worldwide locations. With short interest near 50% of float, he would expect Beyond Meat shares to "squeeze sharply higher," Grundy tells investors. If McDonald's were to pursue a broader roll-out in the U.S. of the "PLT" burgers, it could add greater than 40% to his current FY20 sales forecast on a run-rate basis, added Grundy, who keeps a Hold rating on Beyond Meat shares, citing valuation.
NEPT Neptune Wellness
$3.74

-0.03 (-0.80%)

04/09/19
MITR
04/09/19
INITIATION
MITR
Buy
Neptune Wellness initiated with a Buy at GMP Securities
GMP Securities initiated Neptune Wellness with a Buy rating and C$7 price target.
TTM Tata Motors
$8.11

-0.18 (-2.17%)

10/11/18
10/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Huntington Ingalls (HII) downgraded to Sell from Neutral at Goldman Sachs with analyst Noah Poponak saying the company's pace of growth may not support current valuation levels. 2. Ferrari (RACE) downgraded to Hold from Buy at Jefferies with analyst Philippe Jean Houchois saying he re-based his expectations lower to reflect higher upfront investments and a lower quality of earnings as management's new strategy of less volume and more exclusivity takes hold. 3. Valero (VLO) downgraded to Hold from Buy at Tudor Pickering. 4. TransDigm (TDG) downgraded to Neutral from Outperform at Baird with analyst Peter Arment saying the Esterline (ESL) deal is a shift in the company's strategy in buying a "fixer-up asset" with significantly below average returns that will take time to improve. He believes it will be an overhang on the stock near-term. Arment maintained his $365 price target on TransDigm shares. 5. Tata Motors (TTM) downgraded to Hold from Buy at HSBC with analyst Amyn Pirani saying while the company's India business has surprised positively, Jaguar Land Rover's volumes have continued to decline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/08/19
BOFA
02/08/19
DOWNGRADE
BOFA
Neutral
Tata Motors downgraded to Neutral from Buy at BofA/Merrill
02/08/19
NOMU
02/08/19
DOWNGRADE
NOMU
Neutral
Tata Motors downgraded to Neutral from Buy at Nomura Instinet
10/07/19
NOMU
10/07/19
DOWNGRADE
NOMU
Reduce
Tata Motors downgraded to Reduce from Neutral at Nomura Instinet
EPD Enterprise Products
$27.60

-0.32 (-1.15%)

09/03/19
SCOT
09/03/19
INITIATION
Target $35
SCOT
Outperform
Enterprise Products initiated with an Outperform at Scotiabank
Scotiabank started Enterprise Products Partners with an Outperform rating and $35 price target.
04/12/19
MUFG
04/12/19
NO CHANGE
Target $35
MUFG
Overweight
Enterprise Products cash flow more stable than for overall midstream, says MUFG
MUFG analyst Barrett Blaschke kept his Overweight rating and $35 price target on Enterprise Products after its Analyst Day. The analyst says that while the presentation was "relatively unrevealing", it offered insight on the management's view of "everything from crude oil to the petrochemical world." Blaschke remains positive on the stock, stating the company has a "market leading set of assets and a market price that does not currently reflect it."
05/30/19
JRCO
05/30/19
INITIATION
Target $35
JRCO
Buy
Enterprise Products initiated with a Buy at Johnson Rice
Johnson Rice analyst Georg Venturatos initiated Enterprise Products with a Buy and $35 price target.
07/17/19
PIPR
07/17/19
INITIATION
Target $37
PIPR
Overweight
Enterprise Products initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Pearce Hammond started Enterprise Products with an Overweight rating and $37 price target. The analyst views Enterprise Products as the top company in the midstream sector given its integrated value chain, "superb" management team and "self-funding" business model.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

, SPX

S&P 500

$0.00

(0.00%)

20:46
10/15/19
10/15
20:46
10/15/19
20:46
Periodicals
China may retaliate if U.S. Congress passes bill supporting Hong Kong protesters 

Report from Bloomberg.

SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.74

0.59 (2.02%)

, ABT

Abbott

$82.06

2.25 (2.82%)

20:25
10/15/19
10/15
20:25
10/15/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BAC

Bank of America

$29.74

0.59 (2.02%)

ABT

Abbott

$82.06

2.25 (2.82%)

USB

U.S. Bancorp

$53.73

0.47 (0.88%)

PNC

PNC Financial

$141.86

1.38 (0.98%)

BK

BNY Mellon

$44.37

0.47 (1.07%)

ALLY

Ally Financial

$32.03

0.68 (2.17%)

CMA

Comerica

$67.01

1.765 (2.71%)

FHN

First Horizon

$16.13

0.22 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 27

    Oct

  • 07

    Nov

  • 12

    Nov

RIO

Rio Tinto

$51.40

-0.43 (-0.83%)

20:17
10/15/19
10/15
20:17
10/15/19
20:17
Hot Stocks
Rio Tinto reports Q3 Pilbara iron ore output 87.3M tons, up 6% from last year »

Reports Q3 Pilbara iron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNTX

Gentex

$26.98

0.65 (2.47%)

20:16
10/15/19
10/15
20:16
10/15/19
20:16
Initiation
Gentex initiated  »

Gentex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 04

    Nov

VNE

Veoneer

$16.11

0.82 (5.36%)

20:16
10/15/19
10/15
20:16
10/15/19
20:16
Initiation
Veoneer initiated  »

Veoneer initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VC

Visteon

$82.45

0.63 (0.77%)

20:15
10/15/19
10/15
20:15
10/15/19
20:15
Initiation
Visteon initiated  »

Visteon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

DLPH

Delphi Technologies

$14.37

0.45 (3.23%)

20:14
10/15/19
10/15
20:14
10/15/19
20:14
Initiation
Delphi Technologies initiated  »

Delphi Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

BWA

BorgWarner

$37.74

0.68 (1.83%)

20:13
10/15/19
10/15
20:13
10/15/19
20:13
Initiation
BorgWarner initiated  »

BorgWarner initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

LEA

Lear

$121.75

3.94 (3.34%)

20:13
10/15/19
10/15
20:13
10/15/19
20:13
Initiation
Lear initiated  »

Lear initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 04

    Nov

  • 10

    Dec

  • 11

    Dec

DFIN

Donnelley Financial Solutions

$10.54

0.035 (0.33%)

20:12
10/15/19
10/15
20:12
10/15/19
20:12
Initiation
Donnelley Financial Solutions initiated  »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$132.84

2.17 (1.66%)

, TEVA

Teva

$6.96

0.22 (3.26%)

19:17
10/15/19
10/15
19:17
10/15/19
19:17
Periodicals
As part of proposed settlement, Teva offers $15B of free drugs, Bloomberg says »

The report also notes…

JNJ

Johnson & Johnson

$132.84

2.17 (1.66%)

TEVA

Teva

$6.96

0.22 (3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 07

    Nov

WAFD

Washington Federal

$36.81

0.15 (0.41%)

19:04
10/15/19
10/15
19:04
10/15/19
19:04
Earnings
Washington Federal reports Q4 EPS 66c, consensus 65c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

INGR

Ingredion

$81.17

0.94 (1.17%)

19:01
10/15/19
10/15
19:01
10/15/19
19:01
Hot Stocks
Ingredion discloses malware affecting certain data centers »

Ingredion issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

19:01
10/15/19
10/15
19:01
10/15/19
19:01
Periodicals
Pelosi holds off on House vote over impeachment inquiry, Politico says »

House Speaker Nancy…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$298.89

2.88 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$14.40

0.02 (0.14%)

18:59
10/15/19
10/15
18:59
10/15/19
18:59
Hot Stocks
Petrobras signs charter contracts for two FPSO platforms »

Petrobras announced that …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

SNBR

Sleep Number

$46.69

0.48 (1.04%)

, UAL

United Airlines

$87.90

0.9 (1.03%)

18:58
10/15/19
10/15
18:58
10/15/19
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Sleep…

SNBR

Sleep Number

$46.69

0.48 (1.04%)

UAL

United Airlines

$87.90

0.9 (1.03%)

MCK

McKesson

$138.17

4.01 (2.99%)

ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

CAH

Cardinal Health

$47.93

1.16 (2.48%)

FULT

Fulton Financial

$15.90

0.19 (1.21%)

ETN

Eaton

$82.16

1.29 (1.60%)

SFIX

Stitch Fix

$20.83

-0.38 (-1.79%)

MGM

MGM Resorts

$27.87

-0.1 (-0.36%)

JBHT

J.B. Hunt

$111.65

1.985 (1.81%)

IBKR

Interactive Brokers

$47.43

0.26 (0.55%)

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

NTRA

Natera

$39.21

1.01 (2.64%)

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

X

U.S. Steel

$11.43

0.27 (2.42%)

ARCE

Arco Platform

$48.15

0.75 (1.58%)

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 18

    Oct

KKR

KKR

$26.79

0.67 (2.57%)

, DB

Deutsche Bank

$7.79

0.235 (3.11%)

18:21
10/15/19
10/15
18:21
10/15/19
18:21
Periodicals
KKR, partners cancel Latitude Financial IPO, Reuters reports »

KKR (KKR) and its…

KKR

KKR

$26.79

0.67 (2.57%)

DB

Deutsche Bank

$7.79

0.235 (3.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 29

    Oct

  • 04

    Nov

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

18:20
10/15/19
10/15
18:20
10/15/19
18:20
Hot Stocks
Breaking Hot Stocks news story on Tradeweb Markets »

Tradeweb Markets sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 18

    Oct

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

18:17
10/15/19
10/15
18:17
10/15/19
18:17
Syndicate
Tradeweb Markets files to sell 14.8M shares of Class A common stock »

Refinitiv will continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 18

    Oct

TW

Tradeweb Markets

$39.79

-0.14 (-0.35%)

18:16
10/15/19
10/15
18:16
10/15/19
18:16
Earnings
Tradeweb Markets sees Q3 adjusted EPS 27c, consensus 25c »

Sees Q3 revenue $200.98M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 18

    Oct

EDIT

Editas Medicine

$20.30

0.48 (2.42%)

18:15
10/15/19
10/15
18:15
10/15/19
18:15
Hot Stocks
Editas Medicine, AskBio enter research collaboration over in vivo delivery »

Editas Medicine and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$114.78

2.43 (2.16%)

18:03
10/15/19
10/15
18:03
10/15/19
18:03
Periodicals
NV regulators want to ban Steve Wynn from NV casino industry, Reuters says »

The Nevada Gaming Control…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFIX

Stitch Fix

$20.83

-0.38 (-1.79%)

18:00
10/15/19
10/15
18:00
10/15/19
18:00
Hot Stocks
Stitch Fix director buys 150K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

NTRA

Natera

$39.21

1.01 (2.64%)

17:48
10/15/19
10/15
17:48
10/15/19
17:48
Syndicate
Natera files to sell $175M of common stock »

J.P. Morgan, Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$3.36

0.2 (6.33%)

17:45
10/15/19
10/15
17:45
10/15/19
17:45
Earnings
Aquestive backs FY19 revenue $38M-$45M, consensus $42.82M »

Aquestive Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.